Biomerica, Inc. is a global biomedical technology company developing and marketing diagnostic and therapeutic products that diagnose various diseases by analyzing blood, urine, or fecal specimens. The company primarily focuses on tests for gastrointestinal diseases, food intolerances, diabetes, and COVID-19. Biomerica, headquartered in California, also develops InFoods technology for irritable bowel syndrome therapy and Helicobacter pylori products.